DROIA VENTURES
Droia is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease. Droia invests globally in newly founded or early-stage platform companies that apply novel science and innovative technologies to bring first-in-class drug candidates to patients. With our team of seasoned scientists, entrepreneurs and investment professionals we build great companies to save patient lives.
DROIA VENTURES
Social Links:
Industry:
Finance
Founded:
2011-01-01
Status:
Active
Contact:
+35220301236
Email Addresses:
[email protected]
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-28 | Vicinitas Therapeutics | Droia Ventures investment in Series A - Vicinitas Therapeutics | 65 M USD |
| 2022-01-06 | AmbAgon Therapeutics | Droia Ventures investment in Series A - AmbAgon Therapeutics | 85 M USD |
| 2021-07-19 | Frontier Medicines | Droia Ventures investment in Series B - Frontier Medicines | 88.5 M USD |
| 2021-07-09 | Muna Therapeutics | Droia Ventures investment in Series A - Muna Therapeutics | 73 M USD |
| 2021-05-18 | Hummingbird Bioscience | Droia Ventures investment in Series C - Hummingbird Bioscience | 125 M USD |
| 2021-04-06 | Volastra Therapeutics | Droia Ventures investment in Seed Round - Volastra Therapeutics | 32 M USD |
| 2021-02-11 | Cyteir Therapeutics | Droia Ventures investment in Series C - Cyteir Therapeutics | 80 M USD |
| 2020-07-29 | Vico Therapeutics | Droia Ventures investment in Series A - Vico Therapeutics | 31 M USD |
| 2020-05-13 | QurAlis | Droia Ventures investment in Series A - QurAlis | 42 M USD |
| 2020-04-23 | Accent Therapeutics | Droia Ventures investment in Series B - Accent Therapeutics | 63 M USD |